Bristol Myers Squibb and bluebird bio get US FDA nod for Abecma (idecabtagene vicleucel) to treat…
Abecma is a first-in-class BCMA-directed personalised immune cell therapy delivered as a one-time infusion for triple-class…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.